Delivery Order SPE2DB22D3501-SPE2DB25FVM56
Award Date
4/30/25
Potential Completion Date
5/21/25
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,862.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Zeposia 0.92 MG Capsule 30S, with a completion date of May 1, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,186,067 units of the prescription medication Zeposia 0.92 mg Capsule 30s. The firm-fixed-price delivery order, valued at $13,399.71, has a completion date of November 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $13,399.71, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication Zeposia 0.92 MG Capsule 30S, a prescription drug. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Zeposia 0.92 mg capsules, valued at $8,933.14. This is a firm fixed-price delivery order contract with an ultimate completion date of August 23, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm fixed price delivery order is for the supply of Zeposia 0.92 MG Capsule 30S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) for the delivery of Zeposia 0.92 mg capsules. The fixed-price delivery order, valued at $13,399.71, has a completion date of January 11, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,799.42 delivery order is for the medication Zeposia 0.92 MG Capsule 30S and has a completion date of May 14, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to military healthcare...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $4,620.93 for the supply of the drug Zeposia 0.92 mg capsules. The contract, awarded by the Defense Logistics Agency (DLA), has a completion date of December 23, 2024 and utilizes a firm fixed price pricing structure. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,399.71 Firm Fixed Price Delivery Order is for the supply of Zeposia 0.92 mg capsules, with a completion date of June 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,399.71 firm fixed-price delivery order is for the supply of Zeposia 0.92 mg capsules, a specialty pharmaceutical product. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...